📝 Genpharmasec Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Genpharmasec Ltd reported revenue of ₹50 crore for the quarter ended June 2026 (Q1 FY27), up 312.9% from ₹12 crore in the same quarter last year, and down 10.3% sequentially over the March 2026 quarter.
The company reported a net loss of ₹0 crore, against a net profit of ₹1 crore in the same quarter last year.
Operating profit stood at ₹1 crore — an operating margin (OPM) of 1.9%, compared with 7.8% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Genpharmasec Ltd posted revenue of ₹140 crore, a growth of 315.0% over FY25, with a net profit of ₹1 crore (down 62.5% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹178 crore with a net loss of ₹1 crore.
Valuation snapshot
At the current price of ₹1.14, 531592 has a market capitalisation of ₹59 crore.
Within the Trading & Distributors industry, it is the 25th-largest of the 178 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 29.98%, public shareholders 70.02% of Genpharmasec Ltd.